Last reviewed · How we verify

ketamine and propofol

Ain Shams University · FDA-approved active Small molecule

This is a combination of two intravenous anesthetic agents that work synergistically to produce rapid sedation and anesthesia through different mechanisms.

This is a combination of two intravenous anesthetic agents that work synergistically to produce rapid sedation and anesthesia through different mechanisms. Used for Induction and maintenance of general anesthesia, Sedation in intensive care settings.

At a glance

Generic nameketamine and propofol
Also known asKetam
SponsorAin Shams University
Drug classIntravenous anesthetic combination
TargetNMDA receptor (ketamine); GABA-A receptor (propofol)
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Ketamine is an NMDA receptor antagonist that produces dissociative anesthesia while maintaining airway reflexes and hemodynamic stability. Propofol is a GABAergic agent that enhances inhibitory neurotransmission, producing rapid unconsciousness. Together, they are used in anesthetic induction and sedation protocols, with the combination potentially reducing the required doses of each agent.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results